{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:54:53Z","timestamp":1791050093829,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"16","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Elucidation of the mechanisms responsible for aberrant phosphatidylcholine (PC) metabolism in cancer cells may allow identification of novel biomarkers of tumor progression and design of new targeted anticancer therapies. We recently reported up-regulation of PC-specific phospholipases in epithelial ovarian cancer cells (EOC) compared with nontumoral (normal or immortalized) counterparts (EONT). In the present study, we focused, in the same cell systems, on levels, subcellular localization, and activity of PC-specific phospholipase C (PC-PLC), for which a key role in cell proliferation, differentiation, and apoptosis has been shown in several mammalian cells. A 66-kDa PC-PLC isoform, detected in nuclear and cytoplasmic compartments of both EOC and EONT cells, accumulated on the external plasma membrane of cancer cells only, where it colocalized with \u03b21 integrin, in nonraft membrane domains. PC-PLC activity was 3-fold higher in total cell lysates and 5-fold higher in membrane-enriched fractions of EOC compared with EONT cells. Serum deprivation induced in EOC, but not in EONT, cells a 3-fold decrease in PC-PLC activity, associated with a 40% drop in S-phase fraction. The recovery of both variables to their original levels in serum-restimulated (or lysophosphatidic acid\u2013restimulated) EOC cells was strongly delayed, for at least 24 h, in the presence of the PC-PLC inhibitor tricyclodecan-9-yl-potassium xanthate (D609). The S-phase of serum-restimulated EONT cells was not sensitive to D609. These findings warrant further investigations on the role of PC-PLC and on the effects of its inhibition on the pathways responsible for constitutive EOC cell stimulation and cell proliferation. [Cancer Res 2008;68(16):6541\u20139]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-6763","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T00:48:12Z","timestamp":1218588492000},"page":"6541-6549","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Phosphatidylcholine-Specific Phospholipase C Activation in Epithelial Ovarian Cancer Cells"],"prefix":"10.1158","volume":"68","author":[{"given":"Francesca","family":"Spadaro","sequence":"first","affiliation":[{"name":"1Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ramoni","sequence":"additional","affiliation":[{"name":"1Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Mezzanzanica","sequence":"additional","affiliation":[{"name":"2Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Miotti","sequence":"additional","affiliation":[{"name":"2Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Alberti","sequence":"additional","affiliation":[{"name":"2Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Cecchetti","sequence":"additional","affiliation":[{"name":"1Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Iorio","sequence":"additional","affiliation":[{"name":"1Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Dolo","sequence":"additional","affiliation":[{"name":"3Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Canevari","sequence":"additional","affiliation":[{"name":"2Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Podo","sequence":"additional","affiliation":[{"name":"1Section of Molecular and Cellular Imaging, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,8,12]]},"reference":[{"key":"2022061700295778000_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin\u20082007; 55: 43\u201366.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2022061700295778000_B2","doi-asserted-by":"crossref","unstructured":"Ozols RF, Bookman MA, Connolly DC, et al. Focus on epithelial ovarian cancer. Cancer Cell\u20082004; 5: 19\u201324.","DOI":"10.1016\/S1535-6108(04)00002-9"},{"key":"2022061700295778000_B3","doi-asserted-by":"crossref","unstructured":"Negendank WG. Studies of human tumors by MRS: a review. NMR Biomed\u20081992; 5: 303\u201324.","DOI":"10.1002\/nbm.1940050518"},{"key":"2022061700295778000_B4","doi-asserted-by":"crossref","unstructured":"Podo F. Tumour phospholipid metabolism. Review article. NMR Biomed\u20081999; 12: 413\u201339.","DOI":"10.1002\/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U"},{"key":"2022061700295778000_B5","doi-asserted-by":"crossref","unstructured":"Podo F, Sardanelli F, Iorio E, et al. Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases for noninvasive imaging approaches. Curr Mol Imag Rev\u20082007; 3: 123\u201337.","DOI":"10.2174\/157340507780619160"},{"key":"2022061700295778000_B6","unstructured":"Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res\u20081999; 59: 80\u20134."},{"key":"2022061700295778000_B7","unstructured":"Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res\u20082001; 61: 3599\u2013603."},{"key":"2022061700295778000_B8","doi-asserted-by":"crossref","unstructured":"Iorio E, Mezzanzanica D, Alberti P, et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res\u20082005; 65: 9369\u201376.","DOI":"10.1158\/0008-5472.CAN-05-1146"},{"key":"2022061700295778000_B9","doi-asserted-by":"crossref","unstructured":"Ackerstaff E, Glunde K, Bhujwalla ZW. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem\u20082003; 90: 525\u201333.","DOI":"10.1002\/jcb.10659"},{"key":"2022061700295778000_B10","doi-asserted-by":"crossref","unstructured":"Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm\u20082006; 3: 496\u2013506.","DOI":"10.1021\/mp060067e"},{"key":"2022061700295778000_B11","doi-asserted-by":"crossref","unstructured":"Glunde K, Serkova NJ. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics\u20082006; 7: 1109\u201323.","DOI":"10.2217\/14622416.7.7.1109"},{"key":"2022061700295778000_B12","doi-asserted-by":"crossref","unstructured":"Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun\u20082002; 296: 580\u20133.","DOI":"10.1016\/S0006-291X(02)00920-8"},{"key":"2022061700295778000_B13","doi-asserted-by":"crossref","unstructured":"Glunde K, Raman V, Mori N, Bhujwalla ZM. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res\u20082005; 65: 11034\u201343.","DOI":"10.1158\/0008-5472.CAN-05-1807"},{"key":"2022061700295778000_B14","doi-asserted-by":"crossref","unstructured":"Al-Saffar NM, Troy H, Ramirez de Molina A, et al. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res\u20082006; 66: 427\u201334.","DOI":"10.1158\/0008-5472.CAN-05-1338"},{"key":"2022061700295778000_B15","unstructured":"Podo F, Ferretti A, Knijn A, et al. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res\u20081996; 16: 1399\u2013412."},{"key":"2022061700295778000_B16","doi-asserted-by":"crossref","unstructured":"Ramoni C, Spadaro F, Barletta B, Dupuis ML and Podo F. Phosphatidylcholine-specific phospholipases C in mitogen-stimulated fibroblasts. Exp Cell Res\u20082004; 299: 370\u201382.","DOI":"10.1016\/j.yexcr.2004.05.037"},{"key":"2022061700295778000_B17","doi-asserted-by":"crossref","unstructured":"Van Dijk MC, Muriana FJ, de Widt J, Hilkmann H, van Blittezswijk WJ. Involvement of phosphatidylcholine-specific phospholipases C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. J Biol Chem\u20081997; 272: 11011\u20136.","DOI":"10.1074\/jbc.272.17.11011"},{"key":"2022061700295778000_B18","doi-asserted-by":"crossref","unstructured":"Li F, Wu N, Su R-B, et al. Involvement of phosphatidylcholine-selective phospholipases C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. J Cell Biochem\u20082006; 98: 1615\u201328.","DOI":"10.1002\/jcb.20806"},{"key":"2022061700295778000_B19","doi-asserted-by":"crossref","unstructured":"Kahle PJ, Shooter EM, Johnson RM, Verity AN. Phosphatidylcholine-specific phospholipases inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells. Cell Signal\u20081998; 10: 321\u201330.","DOI":"10.1016\/S0898-6568(98)00010-2"},{"key":"2022061700295778000_B20","doi-asserted-by":"crossref","unstructured":"Wang N, Xie K, Huo S, Zhao J, Zhang S, Miao J. Suppressing phosphatidylcholine-specific phospholipases C and elevating ROS level, NADPH oxidase activity and Rb level induced neuronal differentiation in mesenchimal stem cells. J Cell Biochem\u20082007; 100: 1548\u201357.","DOI":"10.1002\/jcb.21139"},{"key":"2022061700295778000_B21","doi-asserted-by":"crossref","unstructured":"Zhao J, Zhao B, Wang W, Huang B, Zhang S, Miao J. Phosphatidylcholine-specific phospholipases C and ROS were involved in chicken blastodisc differentiation to vascular endothelial cell. J Cell Biochem\u20082007; 102: 421\u20138.","DOI":"10.1002\/jcb.21301"},{"key":"2022061700295778000_B22","doi-asserted-by":"crossref","unstructured":"Cifone MG, Rocaioli P, De Maria R, et al. Multiple pathways originated at the Fas\/Apo-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J\u20081995; 14: 5859\u201368.","DOI":"10.1002\/j.1460-2075.1995.tb00274.x"},{"key":"2022061700295778000_B23","doi-asserted-by":"crossref","unstructured":"Liu X, Zhao Q, Araki S, Zhang S, Miao J. Contrasting effects of phosphatidylcholine-specific phospholipases C on apoptosis in cultured endothelial cells. Endothelium\u20082006; 13: 205\u201311.","DOI":"10.1080\/10623320600760423"},{"key":"2022061700295778000_B24","doi-asserted-by":"crossref","unstructured":"von Knethen A, Brune B. PKC \u03b1 depletion in RAW264.7 macrophages following microbial\/IFN\u03b3 stimulation is PC-PLC-mediated. Antioxid Redox Signal\u20082005; 7: 1217\u201322.","DOI":"10.1089\/ars.2005.7.1217"},{"key":"2022061700295778000_B25","doi-asserted-by":"crossref","unstructured":"Ramoni C, Spadaro F, Menegon M, Podo F. Cellular localization and functional role of phosphatidylcholine-specific phospholipases C in NK cells. J Immunol\u20082001; 167: 2642\u201350.","DOI":"10.4049\/jimmunol.167.5.2642"},{"key":"2022061700295778000_B26","doi-asserted-by":"crossref","unstructured":"Spadaro F, Cecchetti S, Sanchez M, Ausiello CM, Podo F, Ramoni C. Expression and role of phosphatidylcholine-specific phospholipase C in human NK and T-lymphocyte subsets. Eur J Immunol\u20082006; 36: 3277\u201387.","DOI":"10.1002\/eji.200635927"},{"key":"2022061700295778000_B27","doi-asserted-by":"crossref","unstructured":"Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol\u20082007; 37: 2912\u201322.","DOI":"10.1002\/eji.200737266"},{"key":"2022061700295778000_B28","doi-asserted-by":"crossref","unstructured":"Moreno-Garcia ME, Lopez-Bojorques LN, Zentella A, Humphries LA, Rawlings DJ, Santos-Argumedo L. CD38 signaling regulates B lymphocyte activation via a phospholipases C (PLC)-\u03b32-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signalling cascade. J Immunol\u20082005; 174: 2687\u201395.","DOI":"10.4049\/jimmunol.174.5.2687"},{"key":"2022061700295778000_B29","doi-asserted-by":"crossref","unstructured":"Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-\u03b2 secretion: implications for inflammatory processes. Proc Natl Acad Sci U S A\u20082004; 101: 9745\u201350.","DOI":"10.1073\/pnas.0308558101"},{"key":"2022061700295778000_B30","doi-asserted-by":"crossref","unstructured":"Luft T, Rodionova E, Maraskovsky E, et al. Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals. Blood\u20082006; 107: 4763\u20139.","DOI":"10.1182\/blood-2005-04-1501"},{"key":"2022061700295778000_B31","doi-asserted-by":"crossref","unstructured":"Glunde K, Jie C, Bhujwalla ZM. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res\u20082004; 64: 4270\u20136.","DOI":"10.1158\/0008-5472.CAN-03-3829"},{"key":"2022061700295778000_B32","doi-asserted-by":"crossref","unstructured":"Clark MA, Shorr RGL, Bomalaski JS. Antibodies prepared to Bacillus cereus phospholipase C cross react with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochim Biophys Res Commun\u20081986; 140: 114\u20139.","DOI":"10.1016\/0006-291X(86)91065-X"},{"key":"2022061700295778000_B33","doi-asserted-by":"crossref","unstructured":"Mateas MV, Uranga RM, Salvador GA, Giusto NM. Coexistence of phosphatidylcholine-specific phospholipase C and phospholipase D activities in rat cerebral cortex synaptosomes. Lipids\u20082006; 41: 273\u201380.","DOI":"10.1007\/s11745-006-5097-3"},{"key":"2022061700295778000_B34","doi-asserted-by":"crossref","unstructured":"Miotti S, Canevari S, Menard S, et al. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer\u20081987; 39: 297\u2013303.","DOI":"10.1002\/ijc.2910390306"},{"key":"2022061700295778000_B35","doi-asserted-by":"crossref","unstructured":"Pellegrini R, Bazzini P, Tosi E, et al. Production and characterization of two monoclonal antibodies directed against the integrin \u03b21 chain. Tumori\u20081992; 78: 1\u20134.","DOI":"10.1177\/030089169207800101"},{"key":"2022061700295778000_B36","doi-asserted-by":"crossref","unstructured":"Bagnoli M, Balladore E, Luison E, et al. Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment. Mol Cancer Ther\u20082007; 6: 762\u201372.","DOI":"10.1158\/1535-7163.MCT-06-0357"},{"key":"2022061700295778000_B37","doi-asserted-by":"crossref","unstructured":"Vachon L, Costa T, Hertz A. GTPase and adenylate cyclase desensitize at different rates in NG108\u201315 cells. Mol Pharmacol\u20081987; 31: 159\u201368.","DOI":"10.1016\/S0026-895X(25)10349-0"},{"key":"2022061700295778000_B38","doi-asserted-by":"crossref","unstructured":"Miotti S, Bagnoli M, Tomassetti A, Colnaghi MI, Canevari S. Interaction of folate receptor with signaling molecules lyn and G(\u03b1)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1. J Cell Sci\u20082000; 113: 349\u201357.","DOI":"10.1242\/jcs.113.2.349"},{"key":"2022061700295778000_B39","doi-asserted-by":"crossref","unstructured":"Sargiacomo M, Sudol M, Tang Z, Lisanti MP. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol\u20081993; 122: 789\u2013807.","DOI":"10.1083\/jcb.122.4.789"},{"key":"2022061700295778000_B40","doi-asserted-by":"crossref","unstructured":"Lee Z, Swaby RF, Liang Y, et al. Lysophosphatidic acid is a major regulator of growth-regulator oncogene \u03b1 in ovarian cancer. Cancer Res\u20082006; 66: 2740\u20138.","DOI":"10.1158\/0008-5472.CAN-05-2947"},{"key":"2022061700295778000_B41","doi-asserted-by":"crossref","unstructured":"McDermott M, Wakelam MJO, Morris AJ. Phospholipase D. Biochem Cell Biol\u20082004; 82: 225\u201353.","DOI":"10.1139\/o03-079"},{"key":"2022061700295778000_B42","doi-asserted-by":"crossref","unstructured":"Chakraborti S. Phospholipase A2 isoforms: a perspective. Cell Signal\u20082003; 15: 637\u201365.","DOI":"10.1016\/S0898-6568(02)00144-4"},{"key":"2022061700295778000_B43","doi-asserted-by":"crossref","unstructured":"Xu L, Shen Y, Joseph T, et al. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochem Biophys Res Commun\u20082000; 273: 77\u201383.","DOI":"10.1006\/bbrc.2000.2907"},{"key":"2022061700295778000_B44","doi-asserted-by":"crossref","unstructured":"Liskovitch M. Cross talk among multiple signal-activated phospholipases. Trends Biochem Sci\u20081992; 17: 393\u20139.","DOI":"10.1016\/0968-0004(92)90007-V"},{"key":"2022061700295778000_B45","doi-asserted-by":"crossref","unstructured":"Larrodera P, Cornet ME, Diaz-Meco MJ, et al. Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis. Cell\u20081990; 61: 1113\u201320.","DOI":"10.1016\/0092-8674(90)90074-O"},{"key":"2022061700295778000_B46","doi-asserted-by":"crossref","unstructured":"Miao J-H, Araki S, Hayashi H. Relationships between phosphatidylcholine-specific phospholipase C and integrins in cell-substratum adhesion and apoptosis in vascular endothelial cells. Endothelium\u20081997; 5: 287\u2013305.","DOI":"10.3109\/10623329709052594"},{"key":"2022061700295778000_B47","doi-asserted-by":"crossref","unstructured":"Fang X, Schummer M, Mao M, et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta\u20082002; 1582: 257\u201364.","DOI":"10.1016\/S1388-1981(02)00179-8"},{"key":"2022061700295778000_B48","doi-asserted-by":"crossref","unstructured":"Singh ATK, Radeff JM, Kunnel JG, Stern PH. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim Biophys Acta\u20082000; 1487: 201\u20138.","DOI":"10.1016\/S1388-1981(00)00096-2"},{"key":"2022061700295778000_B49","doi-asserted-by":"crossref","unstructured":"Van Dijk MC, Muriana FJ, de Vidt J, Hilkmann H, van Blitterswjk WJ. Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. J Biol Chem\u20081997; 272: 11011\u20136.","DOI":"10.1074\/jbc.272.17.11011"},{"key":"2022061700295778000_B50","doi-asserted-by":"crossref","unstructured":"Luberto C, Hannun YA. Shingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation: does sphingomyelin synthase account for the putative phosphatidylcholine specific phospholipase C? J Biol Chem\u20081998; 273: 14550\u20139.","DOI":"10.1074\/jbc.273.23.14550"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/16\/6541\/2592737\/6541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/16\/6541\/2592737\/6541.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:38:49Z","timestamp":1738309129000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/16\/6541\/540738\/Phosphatidylcholine-Specific-Phospholipase-C"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,12]]},"references-count":50,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2008,8,12]]},"published-print":{"date-parts":[[2008,8,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-6763","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22371527","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371515","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371515.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371527.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371524","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371524.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371518.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371518","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496841","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496841.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,12]]}}}